相似文献
1
Stimulation of neutrophil functions by C5a(desArg): an in vitro model of haemodialysis.
Mediators Inflamm. 1992;1(1):61-6. doi: 10.1155/S0962935192000127.
2
Formation of mixed aggregates of human polymorphonuclear leukocytes and platelets by C5a-desArg.
Complement Inflamm. 1991;8(1):25-32. doi: 10.1159/000463174.
3
Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
Mol Cancer Ther. 2010 Aug;9(8):2175-85. doi: 10.1158/1535-7163.MCT-09-1054. Epub 2010 Aug 3.
4
Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.
J Clin Invest. 1981 May;67(5):1383-91. doi: 10.1172/jci110166.
5
Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
Vet Res. 1998 Jan-Feb;29(1):73-88.
6
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins.
Blood. 1994 Jun 1;83(11):3324-31.
7
Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the des-arginine derivative of C5a.
Am J Vet Res. 2000 Aug;61(8):951-9. doi: 10.2460/ajvr.2000.61.951.
8
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
N Engl J Med. 1985 Feb 21;312(8):457-62. doi: 10.1056/NEJM198502213120801.
9
Complement activation and neutrophil aggregation changes during haemodialysis.
Int J Clin Pharmacol Res. 1993;13(6):293-9.
10
C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
J Immunol. 2001 Mar 1;166(5):3410-5. doi: 10.4049/jimmunol.166.5.3410.
本文引用的文献
1
The microestimation of succinate and the extinction coefficient of cytochrome c.
Biochim Biophys Acta. 1959 Jul;34:255-6. doi: 10.1016/0006-3002(59)90259-8.
2
The effect of hemodialysis and C5a des arg on neutrophil subpopulations.
Blood. 1980 May;55(5):777-83.
3
Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.
J Lab Clin Med. 1981 Dec;98(6):823-30.
4
In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
J Clin Invest. 1982 Dec;70(6):1177-83. doi: 10.1172/jci110716.
5
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
Crit Rev Immunol. 1981 Feb;1(4):321-66.
6
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.
Blood. 1980 Jun;55(6):898-902.
7
Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
Proc Eur Dial Transplant Assoc. 1983;19:159-67.
8
Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Kidney Int. 1983 Dec;24(6):764-9. doi: 10.1038/ki.1983.225.
9
Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
Artif Organs. 1984 Aug;8(3):281-90. doi: 10.1111/j.1525-1594.1984.tb04291.x.
10
Zotero 插件